Baxter International Inc. (BAX)
Bear of the Day: Baxter (BAX)
In the world of equities, not all stocks shine brightly in the heavens. Some inevitably find themselves in the shadows, struggling against the tides of market sentiment.
Baxter Stock May Gain Following Five New Injectable Product Launches
BAX launches five new injectible products in the United States, thus further strengthening its U.S Pharmaceuticals business segment.
Is the Options Market Predicting a Spike in Baxter International (BAX) Stock?
Investors need to pay close attention to Baxter International (BAX) stock based on the movements in the options market lately.
Baxter resumes dialysis solution production at its hurricane-hit facility
Baxter International said on Thursday it has resumed production on all dialysis solution manufacturing lines at its North Carolina facility after they were impacted by hurricane-related flooding.
Baxter International Inc. (BAX) Q3 2024 Earnings Call Transcript
Baxter International Inc. (NYSE:BAX ) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ET Company Participants Clare Trachtman - Senior Vice President, Chief Investor Relations Officer Joe Almeida - Chairman, President and Chief Executive Officer Joel Grade - Executive Vice President and Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Securities Robert Marcus - JPMorgan Pito Chickering - Deutsche Bank Vijay Kumar - Evercore ISI Joanne Wuensch - Citi Lawrence Biegelsen - Wells Fargo David Roman - Goldman Sachs Operator Good morning, ladies and gentlemen, and welcome to Baxter International's Third Quarter 2024 Earnings Conference Call. Your lines will remain in a listen-only mode until the question-and-answer segment of today's call.
BAX Stock Falls Despite Q3 Earnings & Sales Beat, Margins Decline
Baxter reports better-than-expected third-quarter results. However, the company's gross and operating margins contract.
Baxter (BAX) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Baxter (BAX) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Baxter International (BAX) Beats Q3 Earnings Estimates
Baxter International (BAX) came out with quarterly earnings of $0.80 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.68 per share a year ago.
Baxter cuts annual profit forecast on hurricane impact
Baxter International cut its annual profit forecast on Friday due to a hurricane-related hit to its intravenous solutions facility, sending its shares down 3.3% in premarket trading.
Strong Demand and Positive Pricing to Drive Baxter's Q3 Earnings
BAX's third-quarter results are likely to benefit from a positive pricing impact and new product launches. However, supply-chain issues are likely to have raised expenses in the quarter.
Countdown to Baxter (BAX) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Evaluate the expected performance of Baxter (BAX) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Kontoor Brands CEO Scott Baxter on Q3 earnings beat
Scott Baxter, Kontoor Brands CEO, joins CNBC's 'The Exchange' to discuss Kontoor's third-quarter earnings beat, the growth of the company through marketing, and more.
